|
[1]WANG FS, FAN JG, ZHANG Z, et al.The global burden of liver disease:the major impact of China[J].Hepatology, 2014, 60 (6) :2099-2108.
|
|
[2]WONG RJ, AGUILAR M, CHEUNG R, et al.Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States[J].Gastroenterology, 2015, 148 (3) :547-555.
|
|
[3]STEPANOVA M, RAFIQ N, YOUNOSSI ZM.Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease:a population-based study[J].Gut, 2010, 59 (10) :1410-1415.
|
|
[4]TILG H, MOSCHEN AR.Evolution of inflammation in nonalcoholic fatty liver disease:the multiple parallel hits hypothesis[J].Hepatology, 2010, 52 (5) :1836-1846.
|
|
[5]QIN J, LI R, RAES J, et al.A human gut microbial gene catalogue established by metagenomic sequencing[J].Nature, 2010, 464 (7285) :59-65.
|
|
[6]COSTELLO EK, LAUBER CL, HAMADY M, et al.Bacterial community variation in human body habitats across space and time[J].Science, 2009, 326 (5960) :1694-1697.
|
|
[7]COMPARE D, COCCOLI P, ROCCO A, et al.Gut-liver axis:the impact of gut microbiota on non alcoholic fatty liver disease[J].Nutr Metab Cardiovasc Dis, 2012, 22 (6) :471-476.
|
|
[8]DAVID LA, MAURICE CF, CARMODY RN, et al.Diet rapidly and reproducibly alters the human gut microbiome[J].Nature, 2014, 505 (7484) :559-563.
|
|
[9]de WIT N, DERRIEN M, BOSCH-VERMEULEN H, et al.Saturated fat stimulates obesity and hepatic steatosis and affects gut microbiota composition by an enhanced overflow of dietary fat to the distal intestine[J].Am J Physiol Gastrointest Liver Physiol, 2012, 303 (5) :g589-g599.
|
|
[10]MORO-SIBILOT L, BLANC P, TAILLARDET M, et al.Mouse and human liver contain immunoglobulin a-secreting cells originating from Peyer's patches and directed against intestinal antigens[J].Gastroenterology, 2016, 151 (2) :311-323.
|
|
[11]YAN AW, FOUTS DE, BRANDL J, et al.Enteric dysbiosis associated with a mouse model of alcoholic liver disease[J].Hepatology, 2011, 53 (1) :96-105.
|
|
[12]LLOPIS M, CASSARD AM, WRZOSEK L, et al.Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease[J].Gut, 2016, 65 (5) :830-839.
|
|
[13]CHEN Y, YANG F, LU H, et al.Characterization of fecal microbial communities in patients with liver cirrhosis[J].Hepatology, 2011, 54 (2) :562-572.
|
|
[14]THIEMANN S, SMIT N, STROWIG T.Antibiotics and the intestinal microbiome:individual responses, resilience of the ecosystem, and the susceptibility to infections[J].Curr Top Microbiol Immunol, 2016, 398:123-146.
|
|
[15]COX LM, YAMANISHI S, SOHN J, et al.Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences[J].Cell, 2014, 158 (4) :705-721.
|
|
[16]SRINIVAS G, MOLLER S, WANG J, et al.Genome-wide mapping of gene-microbiota interactions in susceptibility to autoimmune skin blistering[J].Nat Commun, 2013, 4 (9) :2462.
|
|
[17]GOODRICH JK, WATERS JL, POOLE AC, et al.Human genetics shape the gut microbiome[J].Cell, 2014, 159 (4) :789-799.
|
|
[18]FOLSERAAS T, MELUM E, RAUSCH P, et al.Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci[J].J Hepatol, 2012, 57 (2) :366-375.
|
|
[19]KNIGHTS D, SILVERBERG MS, WEERSMA RK, et al.Complex host genetics influence the microbiome in inflammatory bowel disease[J].Genome Med, 2014, 6 (12) :107.
|
|
[20]SANER FH, NOWAK K, HOYER D, et al.A non-interventional study of the genetic polymorphisms of NOD2 associated with increased mortality in non-alcoholic liver transplant patients[J].BMC Gastroenterol, 2014, 14:4.
|
|
[21]BACKHED F, DING H, WANG T, et al.The gut microbiota as an environmental factor that regulates fat storage[J].Proc Natl Acad Sci U S A, 2004, 101 (44) :15718-15723.
|
|
[22]PINGITORE A, CHAMBERS ES, HILL T, et al.The diet-derived short chain fatty acid propionate improves beta-cell function in humans and stimulates insulin secretion from human islets in vitro[J].Diabetes Obes Metab, 2017, 19 (2) :257-265.
|
|
[23]FURUSAWA Y, OBATA Y, FUKUDA S, et al.Commensal microbederived butyrate induces the differentiation of colonic regulatory T cells[J].Nature, 2013, 504 (7480) :446-450.
|
|
[24]TURNBAUGH PJ, LEY RE, MAHOWALD MA, et al.An obesity-associated gut microbiome with increased capacity for energy harvest[J].Nature, 2006, 444 (7122) :1027-1031.
|
|
[25]SCHWIERTZ A, TARAS D, SCHAFER K, et al.Microbiota and SCFA in lean and overweight healthy subjects[J].Obesity (Silver Spring) , 2010, 18 (1) :190-195.
|
|
[26]MOUZAKI M, COMELLI EM, ARENDT BM, et al.Intestinal microbiota in patients with nonalcoholic fatty liver disease[J].Hepatology, 2013, 58 (1) :120-127.
|
|
[27]JUMPERTZ R, LE DS, TURNBAUGH PJ, et al.Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans[J].Am J Clin Nutr, 2011, 94 (1) :58-65.
|
|
[28]MUSSO G, GAMBINO R, CASSADER M.Obesity, diabetes, and gut microbiota:the hygiene hypothesis expanded?[J].Diabetes Care, 2010, 33 (10) :2277-2284.
|
|
[29]ULVEN T.Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets[J].Front Endocrinol (Lausanne) , 2012, 3:111.
|
|
[30]den BESTEN G, van EUNEN K, GROEN AK, et al.The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism[J].J Lipid Res, 2013, 54 (9) :2325-2340.
|
|
[31]den BESTEN G, BLEEKER A, GERDING A, et al.Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARγ-dependent switch from lipogenesis to fat oxidation[J].Diabetes, 2015, 64 (7) :2398-2408.
|
|
[32]HEBBARD L, GEORGE J.Animal models of nonalcoholic fatty liver disease[J].Nat Rev Gastroenterol Hepatol, 2011, 8 (1) :35-44.
|
|
[33]SCHNABL B, BRENNER DA.Interactions between the intestinal microbiome and liver diseases[J].Gastroenterology, 2014, 146 (6) :1513-1524.
|
|
[34]ZHU W, GREGORY JC, ORG E, et al.Gut Microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk[J].Cell, 2016, 165 (1) :111-124.
|
|
[35]SINN DH, KANG D, CHANG Y, et al.Non-alcoholic fatty liver disease and progression of coronary artery calcium score:a retrospective cohort study[J].Gut, 2017, 66 (2) :323-329.
|
|
[36]SPENCER MD, HAMP TJ, REID RW, et al.Association between composition of the human gastrointestinal microbiome and development of fatty liver with choline deficiency[J].Gastroenterology, 2011, 140 (3) :976-986.
|
|
[37]SWANN JR, WANT EJ, GEIER FM, et al.Systemic gut microbial modulation of bile acid metabolism in host tissue compartments[J].Proc Natl Acad Sci U S A, 2011, 15 (Suppl 1) :4523-4530.
|
|
[38]SCHAAP FG, TRAUNER M, JANSEN PL.Bile acid receptors as targets for drug development[J].Nat Rev Gastroenterol Hepatol, 2014, 11 (1) :55-67.
|
|
[39]SAYIN SI, WAHLSTROM A, FELIN J, et al.Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-betamuricholic acid, a naturally occurring FXR antagonist[J].Cell Metab, 2013, 17 (2) :225-235.
|
|
[40]PRAWITT J, ABDELKARIM M, STROEVE JH, et al.Farnesoid X receptor deficiency improves glucose homeostasis in mouse models of obesity[J].Diabetes, 2011, 60 (7) :1861-1871.
|
|
[41]INAGAKI T, CHOI M, MOSCHETTA A, et al.Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis[J].Cell Metab, 2005, 2 (4) :217-225.
|
|
[42] FANG S, SUH JM, REILLY SM, et al.Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance[J].Nat Med, 2015, 21 (2) :159-165.
|
|
[43]THOMAS C, GIOIELLO A, NORIEGA L, et al.TGR5-mediated bile acid sensing controls glucose homeostasis[J].Cell Metab, 2009, 10 (3) :167-177.
|
|
[44]ZHU L, BAKER SS, GILL C, et al.Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients:a connection between endogenous alcohol and NASH[J].Hepatology, 2013, 57 (2) :601-609.
|
|
[45]PARLESAK A, SCHAFER C, SCHUTZ T, et al.Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease[J].J Hepatol, 2000, 32 (5) :742-747.
|
|
[46]ENGSTLER AJ, AUMILLER T, DEGEN C, et al.Insulin resistance alters hepatic ethanol metabolism:studies in mice and children with non-alcoholic fatty liver disease[J].Gut, 2016, 65 (9) :1564-1571.
|
|
[47]RAHMAN K, DESAI C, IYER SS, et al.Loss of junctional adhesion molecule a promotes severe steatohepatitis in mice on a diet high in saturated fat, fructose, and cholesterol[J].Gastroenterology, 2016, 151 (4) :733-746.e712.
|
|
[48]MIELE L, VALENZA V, la TORRE G, et al.Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease[J].Hepatology, 2009, 49 (6) :1877-1887.
|
|
[49]CANI PD, AMAR J, IGLESIAS MA, et al.Metabolic endotoxemia initiates obesity and insulin resistance[J].Diabetes, 2007, 56 (7) :1761-1772.
|
|
[50]CANI PD, BIBILONI R, KNAUF C, et al.Changes in gut microbiota control metabolic endotoxemia-induced inflammation in highfat diet-induced obesity and diabetes in mice[J].Diabetes, 2008, 57 (6) :1470-1481.
|
|
[51]MENCIN A, KLUWE J, SCHWABE RF.Toll-like receptors as targets in chronic liver diseases[J].Gut, 2009, 58 (5) :704-720.
|
|
[52]MIURA K, KODAMA Y, INOKUCHI S, et al.Toll-like receptor 9promotes steatohepatitis by induction of interleukin-1beta in mice[J].Gastroenterology, 2010, 139 (1) :323-334.e327.
|
|
[53]MIURA K, YANG L, van ROOIJEN N, et al.Toll-like receptor 2and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice[J].Hepatology, 2013, 57 (2) :577-589.
|
|
[54]VIJAY-KUMAR M, AITKEN JD, CARVALHO FA, et al.Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor5[J].Science, 2010, 328 (5975) :228-231.
|
|
[55]WREE A, EGUCHI A, MCGEOUGH MD, et al.NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice[J].Hepatology, 2014, 59 (3) :898-910.
|
|
[56]VANDANMAGSAR B, YOUM YH, RAVUSSIN A, et al.The NLRP3inflammasome instigates obesity-induced inflammation and insulin resistance[J].Nat Med, 2011, 17 (2) :179-188.
|
|
[57]WEN H, GRIS D, LEI Y, et al.Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling[J].Nat Immunol, 2011, 12 (5) :408-415.
|
|
[58]WLODARSKA M, THAISS CA, NOWARSKI R, et al.NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion[J].Cell, 2014, 156 (5) :1045-1059.
|
|
[59]HENAO-MEJIA J, ELINAV E, JIN C, et al.Inflammasomemediated dysbiosis regulates progression of NAFLD and obesity[J].Nature, 2012, 482 (7384) :179-185.
|
DownLoad: